Tahoe Therapeutics has raised $30 million to develop AI models of living cells, leveraging a large dataset of 100 million perturbed cancer cell responses to improve drug discovery and virtual cell modeling, with aims to accelerate cancer treatment development.
Scientists have successfully developed complete models of human day 14 post-implantation embryos using naïve embryonic stem cells (ES cells). This breakthrough in developmental biology and reproductive medicine provides valuable insights into early human development and could have significant implications for studying embryonic development and improving assisted reproductive technologies. The models accurately recapitulate the complex cellular organization and structures of the embryos, including the epiblast, hypoblast, trophoblast-like compartments, and amnion-like and yolk sac-like structures. This research opens up new possibilities for studying human embryogenesis and advancing our understanding of early human development.